Actavis is a global pharmaceutical company focused on developing,
manufacturing and commercializing branded pharmaceuticals, generic and ...
Actavis plc (NYSE: ACT) is a global, integrated specialty pharmaceutical
company focused on developing, manufacturing and distributing generic, brand
Jun 21, 2011 ... Warning letter: Actavis Elizabeth LLC. ... Capsules, CII (Kadian), submitted by
Actavis Elizabeth LLC (Actavis) under cover of Form FDA-2253.
Jan 4, 2016 ... Actavis Elizabeth LLC. Printer-friendly version. Filename: 2015-1659.mp3.
Appeal Number: 2015-1659. Argument Date: Monday, January 4 ...
Aug 10, 2011 ... The defendants (Actavis Elizabeth LLC, Sun Pharmaceuticals Ltd., Sandoz Inc.,
Mylan Pharmaceuticals Inc., Apotex, Inc., Aurobindo Pharma, ...
Mar 17, 2015 ... Actavis plc (NYSE: ACT) has completed the acquisition of Allergan, Inc. (NYSE:
AGN) in a cash and equity transaction valued at approximately ...
Packager: Actavis Elizabeth LLC. Category: HUMAN PRESCRIPTION DRUG
LABEL; DEA Schedule: CIV; Marketing Status: Abbreviated New Drug
Orexo AB et al v. Actavis Elizabeth LLC et al. 1:16-cv-00397; Filed: 05/27/2016;
Case Updated Daily; Latest Docket Entry: 06/03/2016; PACER. Create Alert. ×.
Nov 16, 2012 ... ... pain killer oxycodone for years, Actavis Elizabeth LLC argued Friday in a trial
over whether Purdue's oxycodone patents should be killed.
Pill imprint Logo (Actavis) 155 has been identified as Buprenorphine ...
Manufacturer: Actavis Elizabeth LLC; National Drug Code (NDC): 00228-3155;